These data coincide with reports showing that B cells from ACPA-positive RA patients differentiate less well into plasma cells [56,57] but they stand in contrast to findings that B cells from RA patients show a more activated phenotype based on CD86 and CD69 expression [45,[55], [56], [57]]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.